Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 01/10/2010
PIL Tenormin 100mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/10/2010 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/05/2008 and displayed until 01/10/2010
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 10/01/2008 and displayed until 01/05/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change due to user-testing of patient information
Updated on 07/01/2008 and displayed until 10/01/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change due to user-testing of patient information
Updated on 05/06/2007 and displayed until 07/01/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to side-effects
  • Change from BAN to rINN
Updated on 23/02/2004 and displayed until 05/06/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  atenolol